missing translation for 'onlineSavingsMsg'
Learn More
Please login to your online account to display your discounted pricing

KDR (VEGFR2) Recombinant Human Protein DFS Item

KDR (VEGFR2) Recombinant Human Protein

Manufacturer:  Life Technologies LSPV3660

 View more versions of this product

Catalog No. PV3660



Description

Description

KDR (VEGFR2) is a type III receptor tyrosine kinase. It binds vascular endothelial growth factor with high affinity in vitro, and is expressed early in development by endothelial cell precursors.
Specifications

Specifications

NP_002244
Cell viability, proliferation and function, pharma and biopharma, protein assays and analysis, target and lead identification and validation
68.4kDa
80% by SDS-PAGE
–80°C
1 Each
KDR (VEGFR2), VEGFR
KDR (VEGFR2) was pre-diluted in enzyme dilution buffer and assayed in 50mM Tris (pH 7.5), 10mM MgCl2, 0.25mM EGTA, 0.1mM Na3VO4, 5mM β-glycerophosphate, 2.5mM DTT, 0.01% Triton™ X-100, 200μM ATP, 200μg/mL poly [Glu, Tyr] 4:1 substrate and trace [32P]-γ-ATP for 10 minutes at 30°C
Kinase and inhibitors
VEGF receptors
KDR (VEGFR2) Recombinant Human Protein
Human
0.43mg/mL
3791
KDR (VEGFR2) Recombinant Human Protein
10μg
For research use only. Not for use in diagnostic procedures
Receptor tyrosine kinases
KDR (VEGFR2) Recombinant Human Protein
Kinase assay
Baculovirus
Amino acids 789-1356
892nmoles of phosphate transferred to poly [Glu, Tyr] 4:1 substrate per minute per mg of total protein at 30°C. Activity determined at a final protein concentration of 2μg/mL
His Tag
Documents

For Research Use Only. Not for use in diagnostic procedures.